Although our study therefore does assess HGPs in light of KRAS, BRAF, and MSI status, in-depth genetic association studies on these histopathological phenotypes are needed to limit potential bias, confirm our findings, and investigate other CRC driver genes. This evidence concerns the gene BRAF and colorectal carcinoma.